Murphy Middleton Hinkle & Parker’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Hold |
3,661
| – | – | 0.54% | 56 |
|
|
2026
Q1 | $1.29M | Buy |
+3,661
| New | +$1.31M | 0.6% | 49 |
|
|
2025
Q4 | – | Sell |
-3,629
| Closed | -$1.02M | – | 137 |
|
|
2025
Q3 | $1.02M | Sell |
3,629
-4
| -0.1% | -$1.16K | 0.5% | 58 |
|
|
2025
Q2 | $1.13M | Hold |
3,633
| – | – | 0.63% | 46 |
|
|
2025
Q1 | $1.13M | Hold |
3,633
| – | – | 0.63% | 46 |
|
|
2024
Q4 | $947K | Sell |
3,633
-3
| -0.1% | -$890 | 0.54% | 58 |
|
|
2024
Q3 | $1.17M | Sell |
3,636
-3
| -0.1% | -$981 | 0.63% | 49 |
|
|
2024
Q2 | $1.14M | Sell |
3,639
-110
| -3% | -$32.3K | 0.66% | 46 |
|
|
2024
Q1 | $1.07M | Hold |
3,749
| – | – | 0.62% | 54 |
|
|
2023
Q4 | $1.08M | Sell |
3,749
-3
| -0.1% | -$817 | 0.67% | 49 |
|
|
2023
Q3 | $1.01M | Sell |
3,752
-190
| -5% | -$47.4K | 0.65% | 48 |
|
|
2023
Q2 | $875K | Hold |
3,942
| – | – | 0.55% | 57 |
|
|
2023
Q1 | $953K | Hold |
3,942
| – | – | 0.59% | 52 |
|
|
2022
Q4 | $1.04M | Sell |
3,942
-35
| -0.9% | -$9.38K | 0.65% | 48 |
|
|
2022
Q3 | $896K | Sell |
3,977
-110
| -3% | -$26.7K | 0.62% | 54 |
|
|
2022
Q2 | $994K | Hold |
4,087
| – | – | 0.64% | 52 |
|
|
2022
Q1 | $988K | Hold |
4,087
| – | – | 0.53% | 55 |
|
|
2021
Q4 | $919K | Hold |
4,087
| – | – | 0.49% | 64 |
|
|
2021
Q3 | $869K | Sell |
4,087
-4
| -0.1% | -$921 | 0.5% | 65 |
|
|
2021
Q2 | $997K | Buy |
4,091
+37
| +0.9% | +$9.1K | 0.56% | 58 |
|
|
2021
Q1 | $1.01M | Sell |
4,054
-32
| -0.8% | -$7.63K | 0.59% | 54 |
|
|
2020
Q4 | $939K | Sell |
4,086
-116
| -3% | -$26.7K | 0.63% | 51 |
|
|
2020
Q3 | $1.07M | Sell |
4,202
-177
| -4% | -$43.9K | 0.78% | 46 |
|
|
2020
Q2 | $1.03M | Hold |
4,379
| – | – | 0.76% | 49 |
|
|
2020
Q1 | $888K | Hold |
4,379
| – | – | 0.78% | 48 |
|
|
2019
Q4 | $1.06M | Hold |
4,379
| – | – | 0.7% | 51 |
|
|
2019
Q3 | $847K | Hold |
4,379
| – | – | 0.6% | 55 |
|
|
2019
Q2 | $807K | Hold |
4,379
| – | – | 0.57% | 57 |
|
|
2019
Q1 | $832K | Hold |
4,379
| – | – | 0.57% | 55 |
|
|
2018
Q4 | $852K | Sell |
4,379
-43
| -1% | -$8.39K | 0.65% | 51 |
|
|
2018
Q3 | $917K | Hold |
4,422
| – | – | 0.65% | 54 |
|
|
2018
Q2 | $816K | Hold |
4,422
| – | – | 0.61% | 55 |
|
|
2018
Q1 | $754K | Hold |
4,422
| – | – | 0.59% | 57 |
|
|
2017
Q4 | $769K | Buy |
+4,422
| New | +$783K | 0.57% | 55 |
|
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
Murphy Middleton Hinkle & Parker's AMGN Position: Q2 2026 in Review
Murphy Middleton Hinkle & Parker held its Amgen (AMGN) position steady in Q2 2026 at 3,661 shares worth $1.33M. The position accounts for 0.54% of the portfolio, ranked #56.
Murphy Middleton Hinkle & Parker first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. 676 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Murphy Middleton Hinkle & Parker held 3,661 shares of Amgen worth $1.33M as of Q2 2026.
- Murphy Middleton Hinkle & Parker left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.54% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #56 holding.
- Murphy Middleton Hinkle & Parker first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- 676 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.